Not only did VCT save AXIS time and monies by not screening an ineligible subject, we improved subject safety at both sites
Garden City, New York (PRWEB) August 12, 2015
AXIS Clinicals USA has selected the Verified Clinical Trials (VCT) national clinical trial database registry to stop attempts at dual enrollment in clinical trial research, thus preventing protocol deviations, improving data quality, and promoting subject safety. Within the first seven days of use, the VCT system proved its worth by stopping a subject’s attempt at dual enrollment. Verified Clinical Trials is the largest North American database registry in both early and late phase clinical trials.
Simultaneously enrolling in multiple clinical trials, also known as Dual Enrollment has become a serious problem in the clinical research world as research volunteers attempt to jump from one study to another without waiting for the appropriate amount of time to lapse between studies. This is typically done in effort to earn more money or receive free care. By doing this, others are placed at risk including the drug manufacturer, the research site, and, most importantly, the volunteer. Furthermore, this may result in issues with the data quality. AXIS Clinicals USA has taken a major step by choosing the Verified Clinical Trials (VCT) system to stop professional research subjects from dual enrollment. AXIS is committed to volunteer safety and data quality; hence implementing this research subject database registry system has increased safety measures by preventing numerous protocol deviations.
Dr. Mitchell Efros, CEO of Verified Clinical Trials (VCT), stated, "In a proactive move, AXIS Clinicals USA is the first clinical research unit in Minnesota to endeavor to protect their research subjects and promote safety and data quality. AXIS Clinicals USA is committed to ensuring that their research subjects do not prematurely enroll in a clinical trial before it is safe following exposure to a prior investigational product.”
Kerri Weingard, ANP COO, added, "With three units in close proximity in the region, it is vital to protect the welfare of the research subjects that may attempt to enroll in multiple trials simultaneously or prior to the mandated and safe designated wash out period. While we witness research subjects travelling across North America every day to break the rules designed to protect them, there is no doubt that having units clustered near each other increases the risks of attempted duplicate enrollment. We applaud AXIS Clinicals USA for taking the appropriate first steps.” Ms. Weingard further added, “Within the first seven days of utilizing the VCT database, AXIS prevented a subject who was actively enrolled in another trial from screening at their site. This commonly attempted protocol violation prevention is exactly why we are so excited to introduce our services to CPUs like AXIS. Not only did VCT save AXIS time and monies by not screening an ineligible subject, we improved subject safety at both sites. AXIS is just on the cusp of realizing how VCT can improve subject safety and data quality across all their studies.”
Dr. Anthony Godfrey, Vice President, Clinical Operations, stated, “We have long recognized the issue of duplicate enrollment in clinical trials and the need to protect the research subject’s health while improving the quality of the data we collect. At AXIS, we are committed to safety and chose to be the first in the region to initiate use of the Verified Clinical Trials system. Selecting Verified Clinical Trials was an easy choice given the large coverage of the network and all of the services and protections provided.”
John D. Peterson, Pharm.D., R.Ph, added, “We are acutely aware of the issues surrounding the professional research subject. While we know volunteers will travel great distances to enroll in more than one trial too soon - having three units in close proximity in the region only increases the chances of duplicate enrollment and protocol violations.”
About AXIS Clinicals USA:
AXIS Clinicals USA is a full service CRO for all your clinical research needs. Our expert professional staff has extensive experience in clinical research and a proven track record. Our state of the art 120,000 square foot facility in Dilworth, MN was purpose-built to maintain an ideal volunteer flow to accommodate multiple studies at the same time. Our state of the art bio-analytical center, equipped with LCMS, UPLC, Hamilton Nimbus and Watson LIMS, is capable of handling more than 15,000 samples per month. Our dedicated 6,000 square foot Dermatology Center can accommodate more than 100 outpatient visits per hour for irritation/sensitization scoring or any adhesion evaluation. Our close proximity to three large universities gives us access to over 20,000 students throughout the year. We have a full licensed Pharmacy in-house capable of procuring and dispensing Schedule II to V products.
About Verified Clinical Trials:
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials, and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and Pharmaceutical Sponsor that prove invaluable with regards to financial and legal issues and liabilities. Verified Clinical Trials prevents several other key protocol deviations. For more information, RSVP to or visit
Verified Clinical Trials Contact:
Mitchell Efros MD FACS
Phone: (516) 998-7499